Abstract This paper explains that BristolMeyersSquibbCorporation's (BMSC) primary strengths is its success at marketing its leading products in a highly competitive sector of the healthcare industry. The author points out that BMSC's performance in the marketplace is based on a thorough knowledge of its retail customers and its end consumer, which is obtained through marketing research. The paper describes the internal dimensions, such as perceptual filter, and external dimensions, such as culture, which influence consumer choice. The author underscores that the benefit of utilizing marketing research to identify these factors of consumer behavior is that BMSC can more appropriately formulate its market strategies The paper relates that the marketing plan applies resources to the identified consumer information to develop an effective marketing strategy.
Table of Contents
Overview
Influences
The Marketing Plan
Conclusion
From the Paper "Part of the proper identification of a consumer need, particularly in the health care industry, is identifying the correct geographic areas within which the target consumers are primarily located. This is important for several reasons but primarily ensures that the proper market is reached, that the right product or service is placed before the consumer, and that duplication of services is avoided. These considerations are all requisite to the strategic planning process in conceiving the entire marketing plan, but particularly in delineating the correct geographic, and geo-demographic areas where the targeted consumers are physically located."
Abstract This paper discusses the pharmaceutical industry and the Bristol Myers Squibb Company (BMSC). It explores the internal and external forces within the pharmaceutical industry and BMSC's response to them are examined in detail. Additionally, the competitive forces within the industry are examined in relation to BMSC's strategic response to them. This is followed by a critical review of BMSC's strategic responses and their effectiveness. Finally, BMSC's corporate leadership and governance are discussed with some final observations on BMSC's corporate responsibility policies and organizations.
From the Paper "This research document discusses the pharmaceutical industry and the Bristol Myers Squibb Company (BMSC). The internal and external forces within the pharmaceutical industry and BMSC's response to them are examined in detail. Additionally, the competitive forces within the industry are examined in relation to BMSC's strategic response to them. This is followed by a critical review of BMSC's strategic responses and their effectiveness. Finally, BMSC's corporate leadership and governance are discussed with some final observations on BMSC's corporate responsibility policies and organizations. Bristol Myers Squibb and the Pharmaceutical Industry Bristol Myers Squibb Overview Bristol Myers Squibb Company's (BMSC) recent history can essentially be summed up by its battle with Pfizer to gain control of the cardiovascular drug market with its Pravachol, Plavix, and other cardiovascular related drugs. However, perhaps one of its greatest marketing mishaps in this regard was its failed test that resulted in ..."
Abstract The paper reveals that Bristol Myers Squibb Company's (BMSC) recent history can be summed up by its battle with Pfizer to gain control of the cardiovascular drug market. The paper provides an overview of Pfizer and offers a competitor profile matrix. The paper then discusses the industry rivalry and includes a SWOT analysis. The paper concludes that BMSC has developed a very integrated manufacturing and distribution network that has allowed it to capitalize on its brand image as a leading pharmaceutical company. The paper provides recommendations and includes an appendix detailing the company's background.
Outline:
The Competitive Environment
BMSC in the Marketplace
Conclusions & Recommendations
From the Paper "The degree of industry rivalry in the pharmaceutical industry is high and potentially debilitating even for the larger competitors. Proctor identifies five levels of competition that most enterprises face in today's hyper-competitive marketplace: direct, close, similar products, substitute products and indirect competition (2000, p.103). These levels of competition vector with Porter's five forces model of competition whereby he models the relationship in the marketplace between competitive forces that together form a core of rivalry that is measured in degrees of intensity (Proctor, 2000). For the pharmaceutical industry, the degree of intensity in competitive forces is extremely high because the risks at stake are considerable; often in the 100s of millions to the billions."
Abstract This paper presents an overview of pharmaceutical company, Bristol Myers Squibb (BMSC) and then presents an environmental analysis of the pharmaceutical industry with regards to how BMSC can obtain a competitive edge. The paper presents a strengths, weaknesses, opportunities, and threats (SWOT) analysis of BMSC and discusses BMSC market segmentation. The paper concludes with recommendations for a marketing strategy.
Table of Contents:
BMSC Overview
The Competitive Environment
Pfizer Overview
Competitor Profile Matrix
Industry Rivalry
Environmental Analysis
BMSC SWOT
Strengths
Weaknesses
Opportunities
Threats
BMSC Segmentation
Conclusion and Recommendations
Conclusions
Recommendations
Appendix
Company Background
SWOT Table
From the Paper "Pfizer had revenues of more than $52,000 million during 2004 which represented an increase of over 17% from the previous year. Pfizer's profit for 2004 was over $11,000 million which represented a year on year increase of over 300%. Financially Pfizer is a very strong company which markets pharmaceutical and consumer products in both human and animal markets concentrated in 3 segments: pharmaceuticals, consumer healthcare and animal healthcare. While continually investing in research and development, Pfizer is currently benefiting from 3 strong products in the marketplace: Viagra, Zoloft and Lipitor."
Tags: pfizer cardiovascular, delay and prosper strategy, integrated online, outsource
Abstract The paper begins by looking at the products of Bristol-Myers Squibb and at the litigation against the company as a result of monopolizing the market. The government's policy on new entrants is discussed in terms of generics. It looks at industry competitors and product substitutes for medication. The paper concludes with a study of the suppliers of BMS and a look at who their customers are.
From the Paper "Bristol-Myers Squibb is a major producer and distributor of medicines, nutritional products, and medical imaging equipment. They produce cardiovascular and metabolic medicines, mental health medicines; as well as headache, migraine, nervous system medicines. Some of their brands include: Excedrin Migraine over the counter medicine, and Enfamil infant formulas. They also produce Boost nutritional supplements and diabetic nutritional products.
Unfortunately, they also have some bad habits. For example, there were two anti-trust suits filed against them, for monopolizing the market in order to delay, or stop, the generic versions of the anti-cancer drug Taxol, and the anti-anxiety drug Buspar. The company was able to do this through manipulation of loopholes in the Hatch-Waxman Act. Under this act, brand name manufacturers list un-expired patents with the FDA in a listing, or compendium, known as the "Orange Book". This listing offers a reward of an automatic 30-month stay against certain potential generic entrants who have been sued for product infringement."
Abstract This paper briefly examines Bristol-Myers Squibb's (BMS) entry into the market and discusses what new innocations this company has to offer the pharmaceutical industry. The paper then addressses the issue of market competition and discusses the different competitive players in the industry. It then explains product substitutes that BMS produces and concludes by mentioning its suppliers and buyers.
From the Paper "Bristol-Myers Squibb is a major producer and distributor of medicines, nutritional products, and medical imaging equipment. They produce cardiovascular and metabolic medicines, mental health medicines; as well as headache, migraine, nervous system medicines. Some of their brands include: Excedrin Migraine over the counter medicine, and Enfamil infant formulas. They also produce Boost nutritional supplements and diabetic nutritional products."
Tags: medicine, natural, remedy, buyer, seller, market, competition, FDA
Abstract This paper explores the issues and history of corporate taxation. Corporations are taxed at a rate depending on their income. This paper discusses the pros and cons of dropping the corporate tax, the methods which can be used to drop or lower corporate taxes and why. The paper includes charts and statistics concerning corporate taxes.
Table of Contents
I. The Beginning of Corporate Income Tax
II. The 1986 Tax Reform Act
III. How Does Taxes Affect Business
IV. Corporate Tax Rates
V. Decline of the Corporate Income Tax
VI. Why the Wide Range Between State and Corporate Taxes
VII. How Does Corporate Tax Work with Multi-state Manufacturers?
VIII. Does the Corporate Tax Help
IX. Proposals of Corporate Income Tax
X. Need of Stimulus
XI. Future Research Concerning Corporate Taxes
XII. Conclusions
XIII. Works Cited
From the Paper "Where did the corporate income tax begin? How does it affect our economy? What is the future of the corporate income tax? Will deleting corporate income tax be the answer for the economy? What about cutting part of this tax? How does the corporate income tax help the economy? These are questions that will be answered in this paper as well as how the corporate tax is affecting our economy now.
The Beginning of Corporate Income Tax
"How the corporate tax began is an example of why tax systems can be worse than they should be and how little influence the economic profession has on government policy (Norton 2). Sometimes ideals look great when they are not that sound. Corporate taxes were used during wartime until 1909, when Congress enacted a 1 percent tax on corporation income. The rate increased until 1932 to 12.5 percent when the rate was changed to the progressive rates. Norton stated, ?Surtaxes on corporate income were added for "excess profits" during both world wars. The highest peacetime rate, 52.8 percent, was reached in the sixties? (2). "
Abstract In this article, the writer critically evaluates the key success factors that corporations that are successfully managing corporate entrepreneurship programs have in common as well as which factors vary. The writer addresses the issue of how competitors to companies who have successfully put corporate entrepreneurship programs into place attempt to create comparable entrepreneurial climates and copy processes proven to be successful. Four companies who have successfully used corporate entrepreneurship programs are used as the basis of this analysis.
Outline:
Executive Summary
Introducing IBM's Emerging Business Opportunity (EBO) Unit
Nokia's Approach to Corporate Entrepreneurship
Toshiba's Unorthodox Laptop Journey
Trilogy Software and the Indian Corporate Entrepreneurship Connection
Summary
References
From the Paper "The EBO process within IBM quickly became one that had three parameters associated with project progress. These include project-based milestones, financials, and assessments of the specific business' maturity. As IBM's culture is heavily focused on metrics of performance, additional milestones included market acceptance including the number of customer pilots, customer references and design-ins, mentions by key industry analysts, product development checkpoints, internal execution, and software vendor partnerships. EBO-based initiatives also were staffed with the most senior members of the management team, and while these seasoned veterans complained they felt they were being actually demoted, in fact EBO leadership gave them the opportunity to gain a higher level of visibility than was the case before."
An assessment of the competing claims of the stockholder stakeholder approaches to corporate social responsibility, and a look at similarities and differences of each type of approach to responsibility.
2,515 words (approx. 10.1 pages), 10 sources, 2001, $ 76.95
Abstract This essay will discuss the competing claims of both the stockholder and the stakeholder approaches to corporate social responsibility. An explanation for corporate social responsibility will be provided and arguments will be put forward for similarities and differences in the stockholder and stakeholder approaches to this movement. Evidence to support these arguments will be provided throughout the essay.
From the paper:
"Before discussing the competing claims, it must be understood what is meant by the term corporate social responsibility. Corporate social responsibility is just one aspect of business ethics and has become increasingly important for companies operating in the global economy. It is a fast developing and increasingly competitive field. There is no single, commonly accepted definition of corporate social responsibility but it generally refers to the idea that businesses are accountable for the effects of their actions on the community and should seek socially and economically beneficial results. It involves operating a business in a way that meets ethical and legal standards as well as meeting public expectation. Decisions taken by managers need to satisfy the needs of the community and companies must be accountable for the way in which their results are achieved."
Abstract Schools claim that children are protected from abuse. Studies of stress symptoms resulting from corporal punishment in schools evidence short and long term psychological damage. Academically, corporal punishment has the distinct effect of reducing the self-esteem of a child. Socially, the child victim of corporal punishment experiences a multiplicity of effects. Spanking and other forms of corporal punishment of children may paradoxically cause an increase in antisocial behavior. The behavior problems associated with corporal are not confined to aggression and other anti-social behaviors by children.
Abstract This paper presents the identification and analysis of corporate governance issues at Alltel corporation. It describes the company and defines elements of corporate governance. The paper concludes that the company is guilty of the appearance of inproprieties. It recommends the company should adopt a policy of not funding unregulated business operations from the earnings of regulated business operations, and eliminate the requirement for a mandatory equity position for the Board of Directors.
From the Paper "The purpose of this research is to analyze relevant corporate governance issues at Alltel Corporation. This executive summary provides description of the company as well as providing a ..."
Abstract This paper examines the history of the use of corporal punishment in American education. It look at the traditional use of corporal punishment in American schools and homes since Colonial times. The paper discusses the reasoning, sociopolitical and spiritual factors motivating the use of corporal punishment in schools and describes forms of corporal punishment.
Abstract This paper examines corporate crime and applies conflict theory to this type of crime. Firstly, it defines corporate crime. It then critiques the conflict theory. The paper argues that conflict theory can be used to explain why corporate crime is abundant and why it is not often persecuted. It also discusses, according to conflict theory, why corporate crimes tend to remain under punished.
From the Paper "Most white collar offenders belong to the "white collar class" - in other words, usually privileged, educated, rich (or at least economically middle class) and usually white and viewed in a different light than the more 'common criminals' and hence punished differently. In most cases they can also afford better and more expensive lawyers, which usually leads to lighter sentences. McDermid Gomme (1998) asserts that recidivism rate is quite high for convicted organizations and high-ranking individuals within these organizations. This can easily be explained by minimal penalties these crimes are given, and deterrence is almost non-existent, but rewards and immediate. Indeed, as McDermid Gomme (1998) notes "fines are so small that business executives generally think of them as modest licensing fees" (446)."
Abstract This paper explores the changes in corporate compliance brought about by the enactment of The Comprehensive Environmental Response, Compensation and Liability Act and the Sarbanes-Oxley Act of 2002. The paper relates that both of these comprehensive legislative initiatives were brought about by infamous events in American Corporate history, and were aimed at preventing such corporate transgressions in the future. They brought personal liability for the actions of the corporation to its directors, officers and management.
From the Paper "The corporate veil was a thick impenetrable barrier that protected Officers, Directors, Management and shareholders from personal liability from the acts of the corporation. The immunity granted by the legislative progenitors of these modern day immortals are now chipping away at the corporate shield, and have created large holes where the long arms of personal liability can now reach. As with all things political, seminal events brought about these fundamental changes in corporate law. The pollution scandal of Love Canal brought about The Comprehensive Environmental Response, Compensation and Liability Act (CERCLA), among other provisions brought about criminal liability to Officers and Management for willful violations (Darragh, 1997, n.p.). The corporate financial scandals associated with the "Dot Bomb" era of the late 1990's resulted in the Sarbanes-Oxley Act of 2002, establishing personal liability to the corporate officers in the reporting of financial data to the Security and Exchange Commission (SEC) (Hein, Neimeth, Rosner & Watts, 2002, n.p.). The spectacular misdeeds of a very few in the corporate world brought about increase personal liability and risk to those that run corporations in America."
Abstract The paper discusses the effectiveness of corporate governance in banking and financial systems in Malawi, an African developing economy. The paper begins with a discussion on the history of Malawi combined with a short explanation of its economy and past laws affecting the banking industry. The banking industry in Malawi is then critiqued along with a general discussion of the manner in which banks operate and affect a country's economy. Next, the paper analyzes the larger financial institutions such as the World Bank and the International Monetary Fund in the context of Malawi's economy. In addition, the available literature on the topic is outlined, broken down into different sections. Furthermore, the paper assesses the effectiveness of corporate governance in Malawi's financial sector and proposes a study for future work. Finally, predicted results of the study are outlined, and well as recommendations for implementing and establishing better guidelines for corporate governance in Malawi's financial services and banking industry.
Outline:
Proposal
Introduction:
Corporate Governance in Malawi
Proposal Conclusion
An Overview of the Role of Commercial Banks
Malawi's Financial Services & Banking System
Literature Review
Public Sector Management
Public Policy Formulation
Decentralization
Corporate Governance
Purpose of the Study & Methodology
Proposed Study Methodology
Conclusion
From the Paper "The effectiveness of corporate governance in Malawi's commercial banks is an important issue given the essential role banks play in the financial systems of developing economies and the widespread banking reforms that these economies have implemented. Although the subject of corporate governance in developing economies has recently received a lot of attention in the literature, the effectiveness of corporate governance of banks in Malawi has been almost ignored by researchers. In developed economies, the corporate governance of banks has only recently been discussed in the literature. In order to address this research deficiency, this paper discusses some of the key concepts and issues for the corporate governance of banks in Malawi that can be applied to other developing economies. In many developing economies, the issue of bank corporate governance is complicated by extensive political intervention in the operation of the banking system. Malawi is a low income country where economic development is a priority for a future stable economy. Economic development consists of capacity building, good governance and economic reform. Acquired skills cannot be utilized fully and institutions cannot operate efficiently without good governance; similarly, economic reform cannot be implemented properly without institutions that are functioning well ."
